Medicine Supply Notification: Fesoterodine (Toviaz® ) 4mg and 8 mg modified release tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fesoterodine (Toviaz®) 4mg and 8 mg modified release tablets.
MSN/2022/031
Tier 2 – medium impact
Date of issue 11th April 2022
- There will be intermittent supply of fesoterodine (Toviaz®) 4mg and 8mg modified release tablets until the end of April 2022.
- Alternative antimuscarinic agents remain available and can support an uplift in demand.
- Generic fesoterodine 4mg and 8mg modified release tablets are being launched and will be available from the beginning of May 2022.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
